Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.

ABSTRACT:

SUBMITTER: Moorman AV 

PROVIDER: S-EPMC11347368 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature